We have a unique database of 1,033 pharmacological compounds which proved to reduce, extend or be neutral to life-extension. This is a huge base for the future Big Data and AI driven research. We can now target the underlying cause of dozens of age-related diseases with new drugs developed upon the research.
We also have 7,000 mouse necropsies that are available for microbiome analysis, brain blood barrier, toxicology, genetic and other kinds of research that we are planning to complete in the coming years in collaboration with universities, big pharma, and other biotech and life science companies.
Our focus is to translate our findings and results into consumer goods industry creating a new type of products (various food categories including dietary supplements) free of toxins and with detoxification potential.